CognitiveCare's Logo
Contact Us Careers Media About Us Stakeholders Platform Solutions
Menu icon png image

Advisory Board Members

Dr Louis Muglia

Dr. Louis Muglia

President and CEO - Burroughs Wellcome Fund

Dr. Louis Muglia, MD PhD is President and CEO of the Burroughs Wellcome Fund, an independent nonprofit research foundation. As a world-renowned clinician, academic and scientist, Dr. Muglia has done seminal work in understanding the molecular timing machinery comprising the biological clock that determines the timing of birth and how this is influenced by the environment, to prevent or better treat human preterm labor and delivery, utilizing genetic and comparative genomic approaches.

Dr. Muglia is a recipient of numerous awards most notably the prestigious "Society of Pediatric Research Young Investigator Award". He has been elected to the American Society for Clinical Investigation and Association of American Physicians. In 2010, Dr. Muglia was elected as a Fellow in the American Association for the advancement of Science. In 2013, Dr. Muglia was elected to membership in the National Academy of Medicine. He has been the recipient of outstanding faculty mentor awards on 7 occasions including Senior Faculty Mentor Award at Cincinnati Children’s, and served as chair of the Board of Scientific Counselors to the NICHD.

Dr Amy Murtha

Dr. Amy Murtha

Dean – RWJ School of Medicine, Rutgers

Dr. Amy Murtha is the dean at RWJ School of Medicine, Rutgers. Previously, Chair of UCSF's Department of Obstetrics, Gynecology and Reproductive Sciences. As a preterm birth researcher, she focuses on identifying the best ways to diagnose and care for patients at risk for preterm birth, particularly for pregnancies complicated by the premature rupture of fetal membranes.

Dr. Murtha is a member of numerous professional societies, including the American College of Obstetricians and Gynecologists; Association of Professors of Gynecology and Obstetrics; Society for Maternal-Fetal Medicine; Society for Reproductive Investigations; Infectious Disease Society for Obstetrics and Gynecology; Sigma Xi Scientific Research Society; Preterm Birth International Collaborative; and Perinatal Research Society.

Dr Rama RamaKrishnan, MIT

Rama RamaKrishnan, PhD

Professor, MIT Sloan School of Management

Dr. Rama Ramakrishnan, PhD is Professor of the Practice, Data Science and Applied Machine Learning at MIT’s Sloan School of Management. Prior to joining MIT, Dr. Rama was Senior Vice President at Salesforce (NYSE: CRM) and Chief Data Scientist for Salesforce Commerce Cloud. In Dr. Rama’s 20+ years of experience as a data science entrepreneur, he has founded or been a senior executive in four software companies that have exited to innovation titans namely, Salesforce, Oracle, and Demandware.

In July 2010, he founded a startup, CQuotient, to build a data-science-based personalization platform for retail and e-commerce. Backed by funding from Bain Capital Ventures, Dr. Rama built and grew the company to a successful exit to Demandware (NYSE: DWRE) in October 2014. CQuotient technology, now known as Salesforce Einstein for Commerce, is one of the top B2C recommendation engines in the world and influences the shopping behavior of billions of consumers annually.

Dr. Errol Norwitz

Dr. Errol Norwitz

President and CEO, Newton-Wellesley Hospital

Dr. Norwitz is currently President of Newton-Wellesley Hospital, and previously served as Chief Scientific Officer at Tufts Medical Center and the Louis E. Phaneuf Professor and Chair of the Department of Obstetrics & Gynecology at Tufts MC and Tufts University School of Medicine.

He is the author of 12 textbooks, 90 book chapters, and more than 250 original research articles and reviews. His research has been supported by NIH/NICHD and March of Dimes. His areas of research interest include the genetics of adverse pregnancy outcome and the molecular regulation of parturition, both at term and preterm.

Dr. Veronica Gillispie-Bell, MD, MAS

Dr. Veronica Gillispie-Bell

Section Head, Women’s Services, Ochsner Health

Dr. Gillispie-Bell is a Board-Certified OB-GYN and Associate Professor for Ochsner Health in New Orleans where she is the Senior Site Lead and Section Head of Obstetrics and Gynecology, the Director of Quality for Women’s Services, and the Medical Director of the Minimally Invasive Center for the Treatment of Uterine Fibroids. Dr. Gillispie-Bell is also the Medical Director of the Louisiana Perinatal Quality Collaborative and Pregnancy Associated Mortality Review for the Louisiana Department of Health. In this role, she leads initiatives in the state of Louisiana to improve birth outcomes for all birthing persons and eliminate disparity gaps.

She has served in several local and national leadership roles and received many accolades for her clinical, academic, and community services contributions. She has authored groundbreaking work pertaining to women’s health and health disparities, served in several local and national leadership roles, and has received numerous accolades for her clinical, academic, and community services contributions.